Anna is a Board-Certified Physician in training at Helios Klinikum Berlin-Buch, where she serves as Assistant Resident in Hematology and Cell Therapy and heads the Clinical Trials Office. She specializes in malignant lymphomas and immunotherapy, notably pioneering CAR-T cell treatment for patients with central nervous system (CNS) lymphoma — an area traditionally excluded from trials. Her retrospective study, demonstrating comparable efficacy and safety in CNS lymphoma cases, earned first prize at the 2024 Helios Clinical Congress and is shaping new treatment standards.

‍